Work

Soluble Epoxide Hydrolase Derived Oxylipins And Cerebral Small Vessel Disease Across Neurodegenerations

Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Cerebral small vessel disease (SVD) is associated with higher ratios of soluble-epoxide hydrolase (sEH) derived linoleic acid (LA) diols (12,13-DiHOME and 9,10-DiHOME) to their parent epoxides (12(13)-EpOME and 9(10)-EpOME). sEH manipulation in animal studies has shown protective effects against Alzheimer’s disease (AD) and Parkinson’s Disease (PD). However, the relationship between sEH and SVD has not yet been examined in stroke, AD, and PD. The relationship between sEH and AD pathologies / PD imaging features has also not been explored. Participants with stroke/cerebrovascular disease (n=159), AD (n=126), and PD (n=139) were recruited across Ontario. Blood samples were taken when fasting. Oxylipins were quantified by ultra-high-performance liquid chromatography – mass spectrometry. Plasma amyloid beta (Aβ) / p-tau181/glial fibrillary acid protein (GFAP) /neurofilament light chain (NfL) markers are quantified through Simoa. Structural and diffusion MRI scans (3T) were employed to quantify small SVD imaging features, brain atrophy, and free water diffusion (FW). Data analysis was conducted using adjusted linear regression models. Among participants with stroke of cerebrovascular origin, those with small vessel stroke (SVS; n=50) exhibited a higher 12,13-DiHOME/12,13-EpOME ratio (β=0.251, P=0.023) compared to individuals with large vessel stroke (n=30). Within the SVS group, a higher 12,13-DiHOME/12,13-EpOME ratio was positively associated with white matter FW (β=0.439, P=0.016) and negatively associated with atrophy (β=-0.277, P=0.031). Both associations exhibited a preference for the temporal lobe in the exploratory regional analyses. The temporal proclivity is independent of the AT(I)N biomarkers, liver function, or kidney function. In participants with stroke / cerebrovascular diseases (9,10-ratio: β=0.180, p=0.010; 12,13-ratio: β=0.112, p=0.125) and AD patients with lacunes (n=98; 9,10-ratio: β =0.242, p=0.015; 12,13-ratio: β =0.202, p=0.045), the ratios were associated with more white matter hyperintensities (WMH). Conversely, in PD patients with lacunes, the ratios were associated with reduced WMH (9,10-ratio: β =0.242, p=0.015; 12,13-ratio: β =0.202, p=0.045). Across the entire cohort, 12,13-EpOME was associated with less WMH, which was modulated by GFAP. Linoleic acid markers of cytochrome P450/sEH activity were associated with SVD across stroke, AD, and PD, with a potential threshold effect. The sEH oxylipins may be involved in SVD related neurodegeneration. The findings may indicate a potential diagnostic biomarker and a novel modifiable risk factor for small vessel disease and related neurodegeneration.
Author: Yu, Di
Language: English
Subfield: Biochemistry
Open Access status: green
OpenAlex ID: W7226059493
Cites: 170
Cited by:
Related to: 10